After the preoperative measurements were performed, one drop of metaoxedrine x3 (Skanderborg Pharmacy, Skanderborg, Denmark), one drop of mydriacyl 10 mg/ml × 3 (Novartis, Basel, Switzerland) and one drop of cyclopentolate 1% × 3 (Alcon Novartis, Forth West, Texas, USA) were instilled in both eyes every ten minutes until three doses of each drug have been administered. A cycloplegic subjective refraction was then performed to ensure a VA of 6/6 (0.00 logMAR) or better in both eyes, and then, ATRRANDOT and ATRTNO were re‐measured to examine reproducibility.
Mydriacyl
Manufactured by Novartis
Sourced in Denmark, United States
Mydriacyl is a pharmaceutical product used for pupil dilation during eye examinations. It contains the active ingredient tropicamide, which is a mydriatic agent that causes temporary enlargement of the pupil.
Automatically generated - may contain errors
2 protocols using mydriacyl
1
Cycloplegic Refraction Protocol
2
Evaluating MMP-9 Immunoassay Interference in Eye Drops
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
To investigate interactions between the MMP-9 immunoassay and components within eye drops, 10 μl of rhMMP-9 (200 ng/ml) was applied to the sample collector, followed by addition of 10 μl of eye drop sample. The following eye drops were used: Elazop (brinzolamide/timolol; Novartis, Basel, Switzerland), Alphagan-P (brimonidine tartrate 0.15%; Allergan, Dublin, Ireland), Isopto Carpine (pilocarpine hydrochloride 2%; Novartis), Bronuck (bromfenac sodium 0.1%; TaeJoon, Seoul, Korea), Cravit (levofloxacin 0.5%; Santen, Tokyo, Japan), Diquas (Diquafosol sodium 3%; Santen), Ikervis (cyclosporine A cationic emulsion 0.1%; Santen, Evry, France), Lotemax (loteprednol etabonate 0.5%; Bausch & Lomb, Rochester, NY, USA), Pazeo (olopatadine hydrochloride 0.7%; Novartis), Lastacaft (alcaftadine 0.25%; Allergan), Mydrin-P (tropicamide 0.5%/phenylephrine 0.5%; Santen), Mydriacyl (tropicamide 1%; Novartis), Cyclogyl (cyclopentolate HCl 1%; Norvatis), Isopto Atropine (atropine hydrochloride 1%; Novartis), and Refresh Tears (carboxymethylcellulose sodium 0.5%; Allergan). The test line was photographed after 10 and 20 min, the density was measured, and the results were compared with a control sample (200 ng/ml of rhMMP-9; 20 μl).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!